ÂÜÀòÂÒÂ×

Mr. Trost joined us in February 2021 as Chief Financial Officer. Previously, he served as Chief Financial Officer of Asklepios BioPharmaceutical, Inc. (AskBio), a biotechnology company, from May 2020 until it was acquired by Bayer AG in October 2020.

Prior to joining AskBio, Mr. Trost served as Senior Vice President, Chief Financial Officer, of Chimerix, Inc. (NASDAQ: CMRX), a biopharmaceutical company, from March 2011. Previous to joining Chimerix, from July 2002 he served as Vice President and Chief Financial Officer at Argos Therapeutics, Inc., a venture-backed immunotherapy company. Prior to this, Mr. Trost served as Senior Vice President and Chief Financial Officer at InteCardia, Inc., a venture-backed cardiac imaging company that was acquired by Syncor International Corporation; and as Executive Vice President and Chief Financial Officer of Coastal Physician Group, Inc. (NYSE: DR), a contract provider of emergency room physicians.

Mr. Trost began his professional career with PwC, last serving as a Senior Manager in the Research Triangle practice.

Mr. Trost holds a B.S. in accounting from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant.